08.10.2012 • NewsSven AbendPeter WilkesPeople

Abend New CEO at Kolb

Effective 1 October 2012, Dr. Sven Abend took over the role as CEO with Kolb. He is replacing Peter Wilkes.

Sven Abend joined Kolb in 2010 as Business Manager for one of the business lines. Since then, his responsibility increased step-wise and with that, Sven was able to get a broader and deeper understanding of Kolb, the markets and its customers.

Next to strengthening the portfolio, it will be Sven's role to continue developing the relationship with KLK.

Kolb is one of the largest alkoxylators in Europe. The company with its headquarters in Switzerland has a presence.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.